Submitted by Anonymous (not verified) on 14 April 2026 - 10:29 Orphan designation: rinatabart sesutecan Treatment of ovarian cancer Positive Link: https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-26-3206Source: What's new